study has been made of the influence of addition of human nh2 terminal glutamic acid plasminogen ( glu-plg ) or human nh2 terminal lysine plasminogen ( lys-plg ) to normal citrated plasma upon the rate of lysis of fully crosslinked plasma clots in the presence of single or two chain urokinase type plasminogen activator ( scu-pa/tcu-pa ) or tissue plasminogen activator ( t-pa ) .
C0086418
human
C0042071
urokinase type plasminogen activator